Stockholm - Delayed Quote SEK
Ascelia Pharma AB (publ) (ACE.ST)
3.1750
+0.0850
+(2.75%)
At close: April 22 at 5:29:52 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-62,844
-62,844
-126,792
-125,263
-116,559
Investing Cash Flow
--
--
47
-65
-38
Financing Cash Flow
115,187
115,187
-936
-1,100
184,871
End Cash Position
75,256
75,256
21,855
149,555
261,599
Capital Expenditure
--
--
--
-65
-38
Issuance of Capital Stock
105,324
105,324
--
295
199,483
Issuance of Debt
33,458
33,458
--
--
--
Repayment of Debt
-7,500
-7,500
--
--
--
Repurchase of Capital Stock
--
--
--
-295
-397
Free Cash Flow
-62,844
-62,844
-126,792
-125,328
-116,597
12/31/2021 - 3/13/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOVIC-B.ST Biovica International AB (publ)
0.7940
-1.00%
19X.SG Axsome Therapeutics Inc
90.74
-1.28%
CLBIO.ST Corline Biomedical AB
8.98
0.00%
HNSA.ST Hansa Biopharma AB (publ)
22.50
+2.37%
96X.F FluoGuide A/S
3.3000
+4.10%
SBMFF Sino Biopharmaceutical Limited
0.4940
0.00%
IMMU.ST Mendus AB (publ)
5.09
+1.39%
EGTX.ST Egetis Therapeutics AB (publ)
3.4900
+3.41%
ACTI.ST Active Biotech AB (publ)
0.0900
-8.16%
FLUI.ST Fluicell AB (publ)
11.90
+2.23%